Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
25.73
-1.73 (-6.30%)
At close: Dec 8, 2025, 4:00 PM EST
25.81
+0.08 (0.31%)
Pre-market: Dec 9, 2025, 4:56 AM EST
Galecto Market Cap
Galecto has a market cap or net worth of $34.15 million as of December 9, 2025. Its market cap has increased by 339.49% in one year.
Market Cap
34.15M
Enterprise Value
26.62M
1-Year Change
339.49%
Ranking
Category
Stock Price
$25.73
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $34.15M, a decrease of -90.74%. That is a compound annual growth rate of -37.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 36.45M | 495.12% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | 316.01M | -14.31% |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |